PG

Procter & Gamble Company
D

PG

Arincen73/100B
165.390
USD
-1.71
(-1.02%)
Post Trading·165.400USD+0.010(+0.01%)
Last updated: · Delayed 15 min
Fair value167.60Plus-1%133Price 165.39204
Q2 FY2027 · Earnings report
EPS estimate 1.81Revenue estimate 22.85B
OverviewFinancialsNewsForecastEarningsDividendsCompany

Procter & Gamble Company revenue 1986–2027

Procter & Gamble Company's revenue in Q1 FY2027, the three months to 30 September 2026, was 23.28B USD, up 4.0% on the same quarter a year before. Procter & Gamble Company's revenue over the last twelve months was 87.92B USD, up 3.5% on the twelve months before. In fiscal year 2026 it was 87.03B USD, up 3.3% on the year before.

Last updated 5 Nov 2026 · Next report 21 Jan 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM30 Sept 202687.92B+3.52%43.77B16.03B
FY202630 Jun 202687.03B+3.26%43.67B16.05B
FY202530 Jun 202584.28B+0.29%43.12B15.97B
FY202430 Jun 202484.04B+2.48%43.19B14.88B
FY202330 Jun 202382.01B+2.27%39.25B14.65B
FY202230 Jun 202280.19B+5.35%38.03B14.74B
FY202130 Jun 202176.12B+7.28%39.01B14.31B
FY202030 Jun 202070.95B+4.83%35.70B13.03B
FY201930 Jun 201967.68B+1.27%32.92B3.90B
FY201830 Jun 201866.83B+2.73%32.40B9.75B
FY201730 Jun 201765.06B-0.37%32.42B15.33B
FY201630 Jun 201665.30B-7.70%32.39B10.51B
FY201530 Jun 201570.75B-4.91%33.69B7.04B
FY201430 Jun 201474.40B-7.13%35.37B11.64B
FY201330 Jun 201380.12B-2.30%40.13B11.31B
FY201230 Jun 201282.01B+1.11%40.60B10.76B
FY201130 Jun 201181.10B+4.56%41.25B11.80B
FY201030 Jun 201077.57B+1.14%40.53B12.74B
FY200930 Jun 200976.69B-6.18%38.00B11.43B
FY200830 Jun 200881.75B+6.89%42.21B12.08B
FY200730 Jun 200776.48B+12.10%39.79B10.34B
FY200630 Jun 200668.22B+20.23%35.10B8.68B
FY200530 Jun 200556.74B+10.38%28.87B6.92B
FY200430 Jun 200451.41B+18.51%26.26B6.16B
FY200330 Jun 200343.38B+7.80%21.24B5.19B
FY200230 Jun 200240.24B+2.53%19.25B4.35B
FY200130 Jun 200139.24B-1.77%17.14B2.92B
FY200030 Jun 200039.95B+4.79%18.44B3.54B
FY199930 Jun 199938.13B+2.61%17.10B3.76B
FY199830 Jun 199837.15B+3.89%16.09B3.78B
FY199730 Jun 199735.76B+1.36%15.25B3.42B
FY199630 Jun 199635.28B+5.38%14.52B3.05B
FY199530 Jun 199533.48B+10.52%13.92B2.65B
FY199430 Jun 199430.30B-0.45%14.08B2.21B
FY199330 Jun 199330.43B+3.65%13.89B-656.00M
FY199230 Jun 199229.36B+8.64%13.09B1.87B
FY199130 Jun 199127.03B+12.23%11.90B1.77B
FY199030 Jun 199024.08B+12.54%10.28B1.60B
FY198930 Jun 198921.40B+10.66%8.79B1.21B
FY198830 Jun 198819.34B+13.74%8.15B1.02B
FY198730 Jun 198717.00B+10.11%7.22B327.00M
FY198630 Jun 198615.44B—6.10B709.00M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Procter & Gamble Company revenue growth by segment

Q1 FY2027 against Q1 FY2026

Fabric Care And Home Care8.20B
+5.3%
Baby, Feminine and Family Care5.32B
+2.9%
Beauty4.41B
+6.4%
Health Care3.32B
+3.0%
Grooming1.89B
+4.0%

Procter & Gamble Company revenue by segment over time

Fabric Care And Home Care Baby, Feminine and Family Care Beauty Health Care Grooming Corporate Fabric & Home Care
Fiscal yearFabric Care And Home CareBaby, Feminine and Family CareBeautyHealth CareGroomingCorporateFabric & Home Care
FY202630.31B +2.4%20.40B +0.8%16.02B +7.1%12.46B +3.8%6.92B +3.8%— —
FY202529.62B +0.4%20.25B -0.1%14.96B -1.7%12.00B +1.7%6.66B +0.1%— —
FY202429.50B +4.0%20.28B +0.3%15.22B +1.4%11.79B +5.1%6.65B +3.7%601.00M -21.4%—
FY202328.37B +3.0%20.22B +2.4%15.01B +1.8%11.23B +3.7%6.42B -2.6%765.00M +2.8%—
FY202227.56B +5.9%19.74B +4.7%14.74B +2.2%10.82B +8.7%6.59B +2.3%744.00M +68.7%—
FY202126.01B +9.6%18.85B +2.6%14.42B +7.9%9.96B +10.3%6.44B +6.1%441.00M +11.6%—
FY202023.74B +7.5%18.36B +3.1%13.36B +3.6%9.03B +9.9%6.07B -2.1%395.00M -18.4%—
FY201922.08B 17.81B -1.5%12.90B +4.0%8.22B +4.6%6.20B -5.4%484.00M -2.6%—
FY2018— 18.08B -0.9%12.41B +8.5%7.86B +4.6%6.55B -1.4%497.00M -1.6%21.44B +3.5%
FY2017— 18.25B -1.4%11.43B -0.4%7.51B +2.2%6.64B -2.5%505.00M +19.7%20.72B

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Procter & Gamble Company's revenue

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.